Stryker (SYK) FCF Payout Ratio Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.71% |
| Dec 31, 2025 | -3.21% |
| Sep 30, 2025 | -3.49% |
| Jun 30, 2025 | -3.93% |
| Mar 31, 2025 | 39.27% |
| Dec 31, 2024 | -12.64% |
| Sep 30, 2024 | -10.98% |
| Jun 30, 2024 | 2.56% |
| Mar 31, 2024 | 51.75% |
| Dec 31, 2023 | 0.99% |
| Sep 30, 2023 | -3.01% |
| Jun 30, 2023 | -5.49% |
| Mar 31, 2023 | 99.67% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | 16.42% |
| Jun 30, 2022 | 2.15% |
| Dec 31, 2021 | 1.60% |
| Sep 30, 2021 | -4.33% |
| Jun 30, 2021 | -3.91% |
| Mar 31, 2021 | -7.76% |
| Dec 31, 2020 | 18.61% |
| Sep 30, 2020 | 26.82% |
| Jun 30, 2020 | -1.24% |
| Mar 31, 2020 | 4.16% |
| Dec 31, 2019 | 13.92% |
| Sep 30, 2019 | 12.12% |
| Jun 30, 2019 | 8.49% |
| Mar 31, 2019 | 4.30% |
| Dec 31, 2018 | 3.86% |
| Sep 30, 2018 | 16.35% |
| Jun 30, 2018 | 16.86% |
| Mar 31, 2018 | -44.51% |
| Dec 31, 2017 | 16.85% |
| Sep 30, 2017 | -78.11% |
| Jun 30, 2017 | 25.16% |
| Dec 31, 2016 | 17.61% |
| Sep 30, 2016 | 15.49% |
| Jun 30, 2016 | -10.29% |
| Mar 31, 2016 | 15.18% |
| Dec 31, 2015 | -45.60% |
| Sep 30, 2015 | -27.49% |
| Jun 30, 2015 | 16.94% |
| Mar 31, 2015 | 9.87% |
| Dec 31, 2014 | 18.91% |
| Mar 31, 2014 | 4.75% |